Physician

Mark Jordan Weisberg, M.D.

According to 2025 Medicare claims, Mark Weisberg, M.D. (NPI: 1568690279) practices internal medicine in the Brownsville-Harlingen, TX market, with the plurality of this provider's patient population coming from Cameron, TX. This provider's primary affiliated billing organization is W&W MEDICAL CONSULTING PLLC (NPI: 1841768280) and primary practice location at 78526-7437. Weisberg is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Weisberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 473 traditional Medicare patients, billed 4,767 HCPCS/CPT codes, and received $593,687 in Medicare payments. The top billing code was 99350 (Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes). Part D data shows 5,588 prescription claims across 536 beneficiaries totaling $313,773 in drug costs, led by Eliquis (Apixaban). DME data shows 516 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $73,331 to $593,687. Similarly, Part D prescription costs have risen steadily, from $6,754 to $313,773. In contrast, DME billing represents a smaller volume and rose steadily, from $2,494 to $44,424.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	358	801	$73,331
2016	441	906	$86,510
2017	361	831	$90,602
2018	113	335	$21,934
2019	404	881	$68,662
2020	186	527	$49,923
2021	419	2,157	$185,959
2022	520	4,816	$520,807
2023	502	5,036	$641,827
2024	473	4,767	$593,687

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	69	205	$6,754
2016	94	255	$7,541
2017	191	394	$14,708
2018	341	876	$81,914
2019	380	754	$43,527
2020	208	704	$51,955
2021	303	1,500	$108,622
2022	337	3,037	$233,648
2023	393	4,001	$246,059
2024	536	5,588	$313,773

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$1,986
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	33	$1,632
2020	N/R	90	$4,483
2021	N/R	95	$4,233
2022	N/R	305	$18,630
2023	N/R	193	$11,126
2024	11	516	$47,740

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99350	Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes	158	654	$135
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	108	119	$131
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	122	396	$90
99349	Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes	107	252	$85
99238	Hospital discharge day management, 30 minutes or less	109	126	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	183	3,294	$63,214
Januvia	Sitagliptin Phosphate	44	795	$15,347
Farxiga	Dapagliflozin Propanediol	33	765	$13,912
Entresto	Sacubitril/Valsartan	24	505	$11,189
Jardiance	Empagliflozin	28	477	$10,858

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4154	Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	41	$14,691
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	N	N/R	13	$9,537
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	21	$5,046
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	31	$4,500
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	11	68	$3,400

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark Jordan Weisberg, M.D.?

Tedicare shows public-source Medicare data for Mark Jordan Weisberg, M.D. (NPI 1568690279), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Jordan Weisberg, M.D. have ACO affiliation data?

Mark Jordan Weisberg, M.D. is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Mark Jordan Weisberg, M.D.?

Mark Jordan Weisberg, M.D. is linked to W&W MEDICAL CONSULTING PLLC (billing NPI 1841768280) in the available physician profile data.

Does Mark Jordan Weisberg, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.